107 related articles for article (PubMed ID: 28947503)
1. The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.
Thierry S; Jdey W; Alculumbre S; Soumelis V; Noguiez-Hellin P; Dutreix M
Mol Cancer Ther; 2017 Dec; 16(12):2817-2827. PubMed ID: 28947503
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.
Herath NI; Berthault N; Thierry S; Jdey W; Lienafa MC; Bono F; Noguiez-Hellin P; Sun JS; Dutreix M
Front Oncol; 2019; 9():1097. PubMed ID: 31781480
[No Abstract] [Full Text] [Related]
3. A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.
Biau J; Devun F; Jdey W; Kotula E; Quanz M; Chautard E; Sayarath M; Sun JS; Verrelle P; Dutreix M
Neoplasia; 2014 Oct; 16(10):835-44. PubMed ID: 25379020
[TBL] [Abstract][Full Text] [Related]
4. [Dbait: An innovative concept to inhibit DNA repair and treat cancer].
Biau J; Devun F; Verrelle P; Dutreix M
Bull Cancer; 2016 Mar; 103(3):227-35. PubMed ID: 26917468
[TBL] [Abstract][Full Text] [Related]
5. The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis.
Herath NI; Devun F; Lienafa MC; Herbette A; Denys A; Sun JS; Dutreix M
Mol Cancer Ther; 2016 Jan; 15(1):15-22. PubMed ID: 26637369
[TBL] [Abstract][Full Text] [Related]
6. AsiDNA Is a Radiosensitizer with no Added Toxicity in Medulloblastoma Pediatric Models.
Ferreira S; Foray C; Gatto A; Larcher M; Heinrich S; Lupu M; Mispelter J; Boussin FD; Pouponnot C; Dutreix M
Clin Cancer Res; 2020 Nov; 26(21):5735-5746. PubMed ID: 32900798
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy.
Quanz M; Berthault N; Roulin C; Roy M; Herbette A; Agrario C; Alberti C; Josserand V; Coll JL; Sastre-Garau X; Cosset JM; Larue L; Sun JS; Dutreix M
Clin Cancer Res; 2009 Feb; 15(4):1308-16. PubMed ID: 19190126
[TBL] [Abstract][Full Text] [Related]
8. Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.
Jdey W; Thierry S; Russo C; Devun F; Al Abo M; Noguiez-Hellin P; Sun JS; Barillot E; Zinovyev A; Kuperstein I; Pommier Y; Dutreix M
Clin Cancer Res; 2017 Feb; 23(4):1001-1011. PubMed ID: 27559053
[No Abstract] [Full Text] [Related]
9. AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance.
Jdey W; Kozlak M; Alekseev S; Thierry S; Lascaux P; Girard PM; Bono F; Dutreix M
Neoplasia; 2019 Sep; 21(9):863-871. PubMed ID: 31362243
[TBL] [Abstract][Full Text] [Related]
10. Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.
Jdey W; Thierry S; Popova T; Stern MH; Dutreix M
Cancer Res; 2017 Aug; 77(16):4207-4216. PubMed ID: 28588010
[TBL] [Abstract][Full Text] [Related]
11. Effect of DNA repair inhibitor AsiDNA on the incidence of telomere fusion in crisis.
Subecz C; Sun JS; Roger L
Hum Mol Genet; 2021 Apr; 30(3-4):172-181. PubMed ID: 33480989
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation.
Devun F; Biau J; Huerre M; Croset A; Sun JS; Denys A; Dutreix M
Radiology; 2014 Mar; 270(3):736-46. PubMed ID: 24475822
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.
Yao H; Qiu H; Shao Z; Wang G; Wang J; Yao Y; Xin Y; Zhou M; Wang AZ; Zhang L
Nanomedicine; 2016 Nov; 12(8):2261-2271. PubMed ID: 27389144
[TBL] [Abstract][Full Text] [Related]
14. Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models.
Biau J; Chautard E; Berthault N; de Koning L; Court F; Pereira B; Verrelle P; Dutreix M
Front Oncol; 2019; 9():549. PubMed ID: 31275862
[TBL] [Abstract][Full Text] [Related]
15. YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
Stachelek GC; Peterson-Roth E; Liu Y; Fernandez RJ; Pike LR; Qian JM; Abriola L; Hoyer D; Hungerford W; Merkel J; Glazer PM
Mol Cancer Res; 2015 Oct; 13(10):1389-97. PubMed ID: 26116172
[TBL] [Abstract][Full Text] [Related]
16. Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma.
Coquery N; Pannetier N; Farion R; Herbette A; Azurmendi L; Clarencon D; Bauge S; Josserand V; Rome C; Coll JL; Sun JS; Barbier EL; Dutreix M; Remy CC
PLoS One; 2012; 7(7):e40567. PubMed ID: 22815765
[TBL] [Abstract][Full Text] [Related]
17. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP
Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989
[TBL] [Abstract][Full Text] [Related]
18. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
[TBL] [Abstract][Full Text] [Related]
19. AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Rhyasen GW; Hattersley MM; Yao Y; Dulak A; Wang W; Petteruti P; Dale IL; Boiko S; Cheung T; Zhang J; Wen S; Castriotta L; Lawson D; Collins M; Bao L; Ahdesmaki MJ; Walker G; O'Connor G; Yeh TC; Rabow AA; Dry JR; Reimer C; Lyne P; Mills GB; Fawell SE; Waring MJ; Zinda M; Clark E; Chen H
Mol Cancer Ther; 2016 Nov; 15(11):2563-2574. PubMed ID: 27573426
[TBL] [Abstract][Full Text] [Related]
20. Lack of Constitutively Active DNA Repair Sensitizes Glioblastomas to Akt Inhibition and Induces Synthetic Lethality with Radiation Treatment in a p53-Dependent Manner.
Palanichamy K; Patel D; Jacob JR; Litzenberg KT; Gordon N; Acus K; Noda SE; Chakravarti A
Mol Cancer Ther; 2018 Feb; 17(2):336-346. PubMed ID: 28838997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
